MTL-HBG

N/A

Report date: 2025/02/14 16:33:59
NME

Base Information

Drug NameMTL-HBG
Drug Alias NameMTL-HBG
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionFetal hemoglobin stimulants
TargetsFetal hemoglobin
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMina Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMina Therapeutics Ltd
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A